LAMP1 and gastric cancer: In the gastric cancer cell line NCI-N87, CD107a expression by NK cells significantly increased from 22.7% (± 2.6%) to 37.3% (± 6.4%) upon trastuzumab co-treatment, confirming a synergistic effect mediated by ADCC (Fig. 4C).